Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Brian S. Biesman, MD, Among First U.S. Doctors Chosen to Administer Newly FDA Approved Restylane Fillers
  • USA - English


News provided by

Goldman Marketing Group

Jan 12, 2017, 13:00 ET

Share this article

Share toX

Share this article

Share toX


My staff and I are proud to be among the first practices in the country to provide these new fillers to our patients. - Dr. Brian S. Biesman

Post this

Nashville, TN (PRWEB) January 12, 2017 -- As the founder of an award-winning practice in Nashville, Dr. Brian S. Biesman is no stranger to participating in exclusive trials with the latest in cosmetic and medical treatments, having participated in the most recent Juvederm® Volbella® trial. Following the recent announcement that Swiss dermatology company Galderma had received U.S. Food and Drug Administration (FDA) approval for two new products, Restylane® Refyne and Restylane® Defyne, in December 2016. Dr. Biesman was chosen among a select few specialists to begin administering the cutting-edge treatments to patients in the U.S. due to his highly recognized work with minimally invasive rejuvenation techniques.

“My staff and I are proud to be among the first practices in the country to provide these new fillers to our patients,” said Dr. Biesman, who is an Assistant Clinical Professor at Vanderbilt University in Nashville and serves on the Medical Advisory Board for several leading providers of injectable and technology-based aesthetic products. “Many of our patients are interested in the most effective, yet minimally invasive options for achieving a more youthful yet natural appearance. Restylane Refyne and Defyne represent another important advance in injectable fillers.”

Restylane Refyne and Restylane Defyne are hyaluronic acid (HA) gel fillers formulated with scientifically-advanced XpresHAn technology to achieve different textures that smooth away lines and wrinkles while also offering flexibility and support. Both have been approved for the treatment of laugh lines or nasolabial folds, which are the lines that run from the sides of the nose to the corners of the mouth. Refyne is specifically designed to treat moderate to severe wrinkles and folds, providing subtle improvements, while Defyne is designed to treat moderate to severe facial wrinkles and folds that lie deeper in the skin.

“I predict that these new Restylane products will be big hits in 2017 because the technology ensures smooth, natural-looking results that last,” said Dr. Biesman, a member of The American Society of Ophthalmic Plastic and Reconstructive Surgery, as well as the American Society for Laser Medicine and Surgery (ASLMS). “Both Refyne and Defyne have proven to remain effective for up to 12 months. Many patients are looking for more advanced treatments that target their specific concerns, and the Restylane family of products offers a wide array of options. My staff and I look forward to helping our patients achieve their aesthetic goals and we are particularly proud to be a part of the exclusive group of practices offering these state-of-the-art treatments.”

About Dr. Brian S. Biesman

Dr. Brian S. Biesman is an oculoplastic surgeon specializing in cosmetic and reconstructive eyelid and facial surgery. He specializes in minimally invasive rejuvenation techniques and is a nationally recognized authority on a variety of non-invasive body sculpting techniques. Dr. Biesman graduated with top honors from the University of Michigan and then did his Ophthalmology residency at the Illinois Eye and Ear Infirmary, after which he did fellowship training in Ophthalmic Plastic and Reconstructive Surgery at Manhattan Eye, Ear, and Throat Hospital.

In addition to being a Clinical Assistant Professor at Vanderbilt University Medical Center, with appointments in Ophthalmology, Dermatology, and Otolaryngology-Head and Neck Surgery, Dr. Biesman is also active in clinical research regarding the latest minimally invasive, technology-based medications, treatments, and products. Furthermore, Dr. Biesman has participated in a variety of clinical trials, including, most recently, that of Juvederm Volbella. He also serves on the Medical Advisory Board for RealSelf, a leading online community in which consumers can learn about and discuss potential elective cosmetic procedures with board-certified physicians and specialists. Dr. Biesman is also on the Medical Advisory Board for ZELTIQ® and Cytrellis, and also serves as a consultant to Allergan, Galderma, Merz, Revance®, and others in the aesthetic space.

Dr. Biesman is the recipient of multiple awards for his contributions to aesthetic oculofacial surgery, laser research, laser-use in patient care, and teaching best laser medicine practices to other physicians. He’s been named one of America’s Best Doctors every year since 2004, and he has memberships in various societies, advisory boards, and editorial boards, including the American Society for Laser Medicine and Surgery (ASLMS), where he served as Laser Safety Officer, Vice-President, and President. He is also a member of The American Society of Ophthalmic Plastic and Reconstructive Surgery, The Tennessee Society for Laser Medicine and Surgery, and the American Academy of Ophthalmology. He is an Honorary Member of the American Society for Dermatologic Surgery.

For more information, please visit: http://drbiesman.com/.

Brian S. Biesman, MD, FACS
345 23rd Ave. N # 416
Nashville, TN 37203
(615) 329-1110
info(at)drbiesman.com

Risa Goldman, Goldman Marketing Group, +1 818-861-7092, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.